...and, snap: Trump will get a cut, and that's the last we'll ever hear about acetaminophen and autism. Before you scoff, the mere fact that the deal is happening right now, after a campaign of attainder originating from the head of state, proves collusion long in advance. If it were otherwise, the price would be mills on the dollar.

This stinks - smells I mean. The timing is just too suspect. Kenvue price tanks upon admin comments that Tylenol is bad, suddenly Kenvue gets bought at a roughly $7 a share premium ($21) vs. the now-tanked price. Mergers take a long time so this was in the works for a while, so I don’t think Kimberly Clark has anything to do with this. One wonders who got the idea to tank the Kenvue stock and then what they did (either on the Kenvue or the Kimberly Clark stock) to profit. Someone should look into this …